EROAD Limited's (NZSE:ERD) 33% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

EROAD Limited (NZSE:ERD) shares have retraced a considerable 33% in the last month, reversing a fair amount of their solid recent performance. Of course, over the longer-term many would still wish they owned shares as the stock's price has soared 107% in the last twelve months.

Although its price has dipped substantially, it's still not a stretch to say that EROAD's price-to-sales (or "P/S") ratio of 1.8x right now seems quite "middle-of-the-road" compared to the Electronic industry in New Zealand, where the median P/S ratio is around 1.9x. However, investors might be overlooking a clear opportunity or potential setback if there is no rational basis for the P/S.

See our latest analysis for EROAD

ps-multiple-vs-industry
NZSE:ERD Price to Sales Ratio vs Industry October 17th 2025
Advertisement

How Has EROAD Performed Recently?

With revenue growth that's inferior to most other companies of late, EROAD has been relatively sluggish. Perhaps the market is expecting future revenue performance to lift, which has kept the P/S from declining. However, if this isn't the case, investors might get caught out paying too much for the stock.

Want the full picture on analyst estimates for the company? Then our free report on EROAD will help you uncover what's on the horizon.

How Is EROAD's Revenue Growth Trending?

The only time you'd be comfortable seeing a P/S like EROAD's is when the company's growth is tracking the industry closely.

Retrospectively, the last year delivered a decent 6.8% gain to the company's revenues. The latest three year period has also seen an excellent 69% overall rise in revenue, aided somewhat by its short-term performance. Accordingly, shareholders would have definitely welcomed those medium-term rates of revenue growth.

Turning to the outlook, the next three years should generate growth of 6.0% per year as estimated by the four analysts watching the company. Meanwhile, the rest of the industry is forecast to expand by 15% per annum, which is noticeably more attractive.

In light of this, it's curious that EROAD's P/S sits in line with the majority of other companies. It seems most investors are ignoring the fairly limited growth expectations and are willing to pay up for exposure to the stock. These shareholders may be setting themselves up for future disappointment if the P/S falls to levels more in line with the growth outlook.

The Final Word

Following EROAD's share price tumble, its P/S is just clinging on to the industry median P/S. While the price-to-sales ratio shouldn't be the defining factor in whether you buy a stock or not, it's quite a capable barometer of revenue expectations.

Our look at the analysts forecasts of EROAD's revenue prospects has shown that its inferior revenue outlook isn't negatively impacting its P/S as much as we would have predicted. At present, we aren't confident in the P/S as the predicted future revenues aren't likely to support a more positive sentiment for long. A positive change is needed in order to justify the current price-to-sales ratio.

And what about other risks? Every company has them, and we've spotted 1 warning sign for EROAD you should know about.

If you're unsure about the strength of EROAD's business, why not explore our interactive list of stocks with solid business fundamentals for some other companies you may have missed.

Valuation is complex, but we're here to simplify it.

Discover if EROAD might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NZSE:ERD

EROAD

Provides electronic on-board units and software as a service to the transport industry in New Zealand, the United States, and Australia.

Adequate balance sheet and slightly overvalued.

Similar Companies

Advertisement

Weekly Picks

DA
davidlsander
OPTH logo
davidlsander on Optimi Health ·

OPTH: A licensed manufacturer already selling MDMA while peers still wait on trials

Fair Value:US$1259.6% undervalued
11 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative
HA
HarishPK
DOX logo
HarishPK on Amdocs ·

Why Amdocs is a high conviction Buy for me?

Fair Value:US$82.0328.6% undervalued
36 users have followed this narrative
3 users have commented on this narrative
12 users have liked this narrative
IV
SBMO logo
Ivoed on SBM Offshore ·

Why SBM Offshore’s €30 Share Price May Be Too Harsh On Its Backlog

Fair Value:€44.524.7% undervalued
22 users have followed this narrative
0 users have commented on this narrative
5 users have liked this narrative
CL
Clive_Thompson
6831 logo
Clive_Thompson on Green Tea Group ·

One of China's Fastest-Growing Restaurant Chains Trades on Just 7x Earnings and an 8% Dividend

Fair Value:HK$8.719.3% undervalued
48 users have followed this narrative
3 users have commented on this narrative
20 users have liked this narrative

Updated Narratives

RO
RockeTeller
STLR logo
RockeTeller on STLLR Gold ·

STLLR Gold, Eric Sprott + Agnico Backed: Massive Canadian Gold Developer at Junior Prices

Fair Value:CA$102.2298.5% undervalued
3 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative
PE
RYTM logo
peter_4mgsy on Rhythm Pharmaceuticals ·

High-Growth Emerging Commercial Stage Biotech

Fair Value:US$13413.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
WO
woodworthfund
RAIL logo
woodworthfund on FreightCar America ·

ALL ABOARD THE VALUE TRAIN: WHY $RAIL MIGHT BE HEADED NORTH - FREIGHTCAR AMERICA - Long term price target of $25

Fair Value:US$2568.4% undervalued
4 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28022.3% undervalued
288 users have followed this narrative
9 users have commented on this narrative
16 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9120.5% overvalued
153 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
KI
AMZN logo
KiwiInvest on Amazon.com ·

Amazon's high growth, high tech segments propel its profits, while traditional segments plod along

Fair Value:US$475.0941.5% undervalued
173 users have followed this narrative
1 users have commented on this narrative
8 users have liked this narrative